What is the financial impact of Derica W. Rice's departure on CVS Health?

The primary financial impact involves the severance package, which includes 18 months of continued base salary. Additionally, the company will pay out a 2019 bonus of $1,847,000 and a pro-rated 2020 bonus of $275,000. The vesting of equity awards also represents a potential future cost or dilution depending on how they are settled.

How will Mr. Rice's equity awards be treated?

Mr. Rice's stock options and restricted stock unit awards (excluding PEP RSUs) will continue to vest through the 18-month severance period. His performance stock unit awards will vest on a pro-rated basis based on actual performance through his separation date. The unvested portion of his PEP RSUs will also vest pro-rated through the separation date.

Are there any other significant payments or benefits included in the separation agreement?

Yes, the agreement includes a one-time lump sum cash payment of $300,000 in lieu of remaining relocation entitlements. Mr. Rice will also be reimbursed for up to $15,000 for tax and financial planning services.

What are the ongoing obligations for Mr. Rice after his departure?

Mr. Rice is subject to customary confidentiality and cooperation covenants, and has released the company from claims. His restrictive covenant agreement, including non-competition clauses, is incorporated into the separation agreement and has been amended to conform to applicable law.

CVS 8-K: Leadership Changes

Summary

This 8-K filing from CVS Health reports on the departure of Derica W. Rice, former Executive Vice President and President of CVS Caremark, effective March 1, 2020. The company has entered into a separation agreement with Mr. Rice, outlining severance payments and the treatment of his equity awards. For investors, the key takeaway is the financial commitment associated with Mr. Rice's departure, including 18 months of continued base salary, a pro-rated bonus for 2020, and the specifics regarding the vesting of his stock options, restricted stock units, and performance stock units. The agreement also includes standard clauses such as a release of claims and confidentiality covenants.

Key Highlights

1Derica W. Rice, EVP and President of CVS Caremark, departed CVS Health effective March 1, 2020.
2A separation agreement was signed on March 3, 2020, detailing Mr. Rice's departure terms.
3CVS Health will provide Mr. Rice with 18 months of continued base salary as severance.
4Mr. Rice's equity awards, including stock options and RSUs, will continue to vest through the severance period, with PSUs vesting on a pro-rated basis.
5Mr. Rice is entitled to a 2019 bonus of $1,847,000 and a pro-rated 2020 bonus of $275,000.
6The separation agreement includes a lump sum payment of $300,000 in lieu of relocation policy entitlements and reimbursement for tax/financial planning services up to $15,000.
7The agreement contains customary confidentiality, cooperation covenants, and a release of claims by Mr. Rice.

CVS HEALTH Corp 8-K Report, Executive Changes (Mar 6, 2020)

Summary

Key Highlights

Frequently Asked Questions